Compare IND. SWIFT with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IND. SWIFT vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IND. SWIFT CIPLA IND. SWIFT/
CIPLA
 
P/E (TTM) x -1.9 30.8 - View Chart
P/BV x - 4.3 - View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 IND. SWIFT   CIPLA
EQUITY SHARE DATA
    IND. SWIFT
Mar-21
CIPLA
Mar-21
IND. SWIFT/
CIPLA
5-Yr Chart
Click to enlarge
High Rs5879 0.6%   
Low Rs2411 0.5%   
Sales per share (Unadj.) Rs65.7237.6 27.7%  
Earnings per share (Unadj.) Rs-5.529.8 -18.5%  
Cash flow per share (Unadj.) Rs0.543.0 1.2%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Avg Dividend yield %00.8 0.0%  
Book value per share (Unadj.) Rs-128.4226.7 -56.6%  
Shares outstanding (eoy) m54.16806.46 6.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.12.7 1.9%   
Avg P/E ratio x-0.621.6 -2.9%  
P/CF ratio (eoy) x6.415.0 42.6%  
Price / Book Value ratio x02.8 -0.9%  
Dividend payout %016.8 0.0%   
Avg Mkt Cap Rs m184519,826 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m51232,518 1.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,561191,596 1.9%  
Other income Rs m1522,698 5.6%   
Total revenues Rs m3,713194,294 1.9%   
Gross profit Rs m40242,487 0.9%  
Depreciation Rs m32710,677 3.1%   
Interest Rs m5221,607 32.5%   
Profit before tax Rs m-29532,901 -0.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m38,888 0.0%   
Profit after tax Rs m-29824,013 -1.2%  
Gross profit margin %11.322.2 50.9%  
Effective tax rate %-1.127.0 -4.1%   
Net profit margin %-8.412.5 -66.8%  
BALANCE SHEET DATA
Current assets Rs m2,652132,095 2.0%   
Current liabilities Rs m7,06245,916 15.4%   
Net working cap to sales %-123.945.0 -275.3%  
Current ratio x0.42.9 13.1%  
Inventory Days Days15368 226.3%  
Debtors Days Days1,1077 16,857.6%  
Net fixed assets Rs m4,064116,277 3.5%   
Share capital Rs m1081,613 6.7%   
"Free" reserves Rs m-7,060181,232 -3.9%   
Net worth Rs m-6,952182,844 -3.8%   
Long term debt Rs m6,44212,028 53.6%   
Total assets Rs m6,716248,372 2.7%  
Interest coverage x0.421.5 2.0%   
Debt to equity ratio x-0.90.1 -1,408.7%  
Sales to assets ratio x0.50.8 68.7%   
Return on assets %3.310.3 32.3%  
Return on equity %4.313.1 32.7%  
Return on capital %-44.517.7 -251.2%  
Exports to sales %74.231.3 237.2%   
Imports to sales %5.010.9 45.4%   
Exports (fob) Rs m2,64359,951 4.4%   
Imports (cif) Rs m17620,911 0.8%   
Fx inflow Rs m2,68268,051 3.9%   
Fx outflow Rs m26020,911 1.2%   
Net fx Rs m2,42247,140 5.1%   
CASH FLOW
From Operations Rs m77237,552 2.1%  
From Investments Rs m-167-23,872 0.7%  
From Financial Activity Rs m-483-13,299 3.6%  
Net Cashflow Rs m122509 24.0%  

Share Holding

Indian Promoters % 55.6 13.5 412.0%  
Foreign collaborators % 0.0 20.1 -  
Indian inst/Mut Fund % 0.0 48.6 -  
FIIs % 0.0 26.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 44.4 66.4 66.9%  
Shareholders   14,009 418,584 3.3%  
Pledged promoter(s) holding % 73.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IND. SWIFT With:   SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    



Today's Market

4 Reasons Why Sensex Rallied 1,534 Points Today(0)

Bulls marked a strong comeback today as Indian share markets ended nearly 3% higher. After opening the day higher, equity markets extended gains as the session progressed and ended near the day's high.

Related Views on News

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Cipla Shares Tank Despite Strong Earnings (Views On News)

Aug 6, 2021

The stock fell 3.5% even as the company reported numbers higher than analysts' expectations.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IND. SWIFT SHARE PRICE


May 20, 2022 (Close)

TRACK IND. SWIFT

  • Track your investment in IND. SWIFT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IND. SWIFT - ALCHEMIST LIMITED COMPARISON

COMPARE IND. SWIFT WITH

MARKET STATS